肝细胞癌PET/CT研究进展  

Progress of PET/CT imaging in hepatocellular carcinoma

作　　者：李天然[1] 

机构地区：[1]解放军总医院第一附属医院放射科,北京100037

出　　处：《胃肠病学和肝病学杂志》2017年第11期1201-1205,共5页Chinese Journal of Gastroenterology and Hepatology

基　　金：国家自然科学基金资助项目(81271607);中国博士后基金(2015M572810);解放军总医院临床科研扶持基金(2017FC-304Z-GLCX-01)

摘　　要：^(18)F-FDG正电子发射断层扫描(positron emission tomography,PET)肝细胞癌(hepatocellular carcinoma,HCC)显像阳性率偏低,^(18)F-FDG PET显像浓聚程度与癌细胞分化程度有关,多种因素影响HCC细胞对^(18)F-FDG的摄取。多种示踪剂联合显像及多模式成像有可能提高HCC诊断的阳性率。PET/CT在转移性肝癌的复发、转移方面价值优于传统影像技术。本文就PET/CT在肝癌方面研究的进展作一概述。The positive rate of 1SF-FDG positron emission tomography （PET） imaging in hepatocellular carcinoma （HCC） is low. The studies indicated that intensity degree of is F-FDG related to the degree of cancer cell differentiation. Many factors affect the lSF-FDG uptake by HCC. Tracers and multiple modalities imaging may improve the positive rate of HCC detection. The value of PET/CT in metastatic liver cancer and prediction of recurrence and metastasis is bettel＇ than traditional imaging techniques. Progress of PET/CT imaging in HCC was reviewed in this article.

关 键 词：PET 18F-FDG 肝细胞癌 CT 

分 类 号：R735.7[医药卫生—肿瘤]